The triterpene hederagenin glucoside saponins and chromane hydrazone 2-(2,3-dihydro-4h-1- benzopyran-4-ylidene) hydrazide as active ingredients of topical formulation to treat cutaneous leishmaniasis

ABSTRACT: Cutaneous leishmaniasis (CL) is an endemic infection worldwide. Due to variable response to therapy and frequency of relapses, a more effective, safe, and inexpensive treatment is needed. Previously it was reported that the hederagenin glucoside saponins (SS) and chromane hydrazone (TC2) c...

Full description

Autores:

Piragauta, Sandra
Higuita Castro, Jorge Luis
Arbeláez Córdoba, Natalia
Restrepo Agudelo, Adriana María
Archbold Joseph, Rosendo
Quiñones Fletcher, Wiston
Torres, Fernando
Echeverri López, Luis Fernando
Escobar Peláez, Gustavo
Vélez Bernal, Iván Darío
Montoya Cuervo, Edwin Andrés
Robledo Restrepo, Sara María

Tipo de recurso:

http://purl.org/coar/resource_type/c_6670

Fecha de publicación:

2022

Institución:

Universidad de Antioquia

Repositorio:

Repositorio UdeA

Idioma:

eng

OAI Identifier:

oai:bibliotecadigital.udea.edu.co:10495/34759

Acceso en línea:

https://hdl.handle.net/10495/34759

Palabra clave:

Leishmaniasis Cutánea
Leishmaniasis, Cutaneous
Triterpenos
Triterpenes
Enfermedades Parasitarias
Parasitic Diseases
Saponinas
Saponins

Rights

openAccess

License

http://creativecommons.org/licenses/by-nc-sa/2.5/co/